ATC codes:
N05CD08
EMLc
Indication
Sedative-hypnotic and anxiolytic drugs
ICD11 code:
XM881358505
INN
Midazolam
Medicine type
Chemical agent
List type
Core
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
1 mg per mL in 5 vial ;
5 mg per mL in 1 mL vial ;
5 mg per mL in 3 mL vial
Oral > Liquid: 2 mg per mL (EMLc)
Oral > Solid > dosage form: 15 mg (EML) ; 7.5 mg (EML)
Oral > Liquid: 2 mg per mL (EMLc)
Oral > Solid > dosage form: 15 mg (EML) ; 7.5 mg (EML)
EML status history
Sex
All
Age
Also recommended for children
Therapeutic alternatives
Medicines within the same pharmacological class can be used
Therapeutic alternatives limitations
Therapeutic alternatives to be reviewed (2023)
Therapeutic alternatives limitations for EMLc
Therapeutic alternatives to be reviewed (2023)
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- to delete midazolam tablets 7.5 mg and 15 mg from the EMLc.
- to modify the formulation descriptions of midazolam injection to better describe the available dosage forms.